Rachel Lees

996 total citations
27 papers, 670 citations indexed

About

Rachel Lees is a scholar working on Pharmacology, Psychiatry and Mental health and Epidemiology. According to data from OpenAlex, Rachel Lees has authored 27 papers receiving a total of 670 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pharmacology, 8 papers in Psychiatry and Mental health and 6 papers in Epidemiology. Recurrent topics in Rachel Lees's work include Cannabis and Cannabinoid Research (24 papers), Substance Abuse Treatment and Outcomes (6 papers) and Bipolar Disorder and Treatment (6 papers). Rachel Lees is often cited by papers focused on Cannabis and Cannabinoid Research (24 papers), Substance Abuse Treatment and Outcomes (6 papers) and Bipolar Disorder and Treatment (6 papers). Rachel Lees collaborates with scholars based in United Kingdom, United States and Australia. Rachel Lees's co-authors include Tom P. Freeman, Chandni Hindocha, Kat Petrilli, Michael Bloomfield, Valerie H. Curran, Abigail M. Freeman, Claire Mokrysz, Matthew B. Wall, Rob Saunders and Sebastian F Green and has published in prestigious journals such as Biological Psychiatry, Neuroscience & Biobehavioral Reviews and Psychological Medicine.

In The Last Decade

Rachel Lees

24 papers receiving 653 citations

Peers

Countries citing papers authored by Rachel Lees

Since Specialization

Citations

This map shows the geographic impact of Rachel Lees's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel Lees with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel Lees more than expected).

Fields of papers citing papers by Rachel Lees

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel Lees. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel Lees. The network helps show where Rachel Lees may publish in the future.

Co-authorship network of co-authors of Rachel Lees

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel Lees. A scholar is included among the top collaborators of Rachel Lees based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel Lees. Rachel Lees is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Longitudinal study of risk factors predicting cannabis use disorder in UK young adults and adolescents 2025 ·Communications Medicine ·(unknown), Donald R. Jones, Claire Mokrysz, Rachel Lees, Kat Petrilli, (unknown), Will Lawn, H. Valerie Curran, Tom P. Freeman	0
2	Associations of cannabis use, tobacco use, and incident anxiety, mood, and psychotic disorders: a systematic review and meta-analysis 2024 ·Psychological Medicine ·(unknown), Tom P. Freeman, Hannah Sallis, Robyn E. Wootton, (unknown), (unknown), Rachel Lees, (unknown), Gemma Taylor	0
3	Persistent increased severity of cannabis use disorder symptoms in adolescents compared to adults: a one-year longitudinal study 2024 ·European Archives of Psychiatry and Clinical Neuroscience ·Rachel Lees, Will Lawn, Kat Petrilli, (unknown), (unknown), Anna Borissova, (unknown), Claire Mokrysz, H. Valerie Curran, Lindsey A. Hines, Tom P. Freeman	6
4	Associations between regular cannabis use and brain resting-state functional connectivity in adolescents and adults 2023 ·Journal of Psychopharmacology ·(unknown), Will Lawn, Claire Mokrysz, Tom P. Freeman, (unknown), Anna Borissova, (unknown), Rachel Lees, (unknown), Kat Petrilli, (unknown), Essi Viding, H. Valerie Curran, Matthew B. Wall	6
5	Effects of cannabidiol on anandamide levels in individuals with cannabis use disorder: findings from a randomised clinical trial for the treatment of cannabis use disorder 2023 ·Translational Psychiatry ·(unknown), Chandni Hindocha, Gianluca Baio, Rachel Lees, (unknown), Celia J. A. Morgan, Ali Mofeez, H. Valerie Curran, Tom P. Freeman	14
6	Effect of four-week cannabidiol treatment on cognitive function: secondary outcomes from a randomised clinical trial for the treatment of cannabis use disorder 2023 ·Psychopharmacology ·Rachel Lees, Lindsey A. Hines, Chandni Hindocha, Gianluca Baio, (unknown), George Stothart, Ali Mofeez, Celia J. A. Morgan, H. Valerie Curran, Tom P. Freeman	13
7	Enhanced cannabis timeline followback (EC‐TLFB): Comprehensive assessment of cannabis use including standard THC units and validation through biological measures 2023 ·Addiction ·Kat Petrilli, Will Lawn, Rachel Lees, Claire Mokrysz, Anna Borissova, (unknown), (unknown), (unknown), (unknown), (unknown), Lindsey A. Hines, Valentina Lorenzetti, H. Valerie Curran, Tom P. Freeman	8
8	The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study 2022 ·Psychopharmacology ·Michael Bloomfield, (unknown), Chandni Hindocha, (unknown), (unknown), (unknown), Ben Statton, Matthew B. Wall, Rachel Lees, Oliver Howes, Valerie H. Curran, Jonathan P. Roiser, Tom P. Freeman	15
9	The CannTeen study: verbal episodic memory, spatial working memory, and response inhibition in adolescent and adult cannabis users and age-matched controls 2022 ·Psychopharmacology ·Will Lawn, (unknown), Claire Mokrysz, (unknown), Rachel Lees, (unknown), Kat Petrilli, Anna Borissova, (unknown), Sarah L. Waters, (unknown), Matthew B. Wall, Tom P. Freeman, Valerie H. Curran	9
10	Neural responses to reward anticipation and feedback in adult and adolescent cannabis users and controls 2022 ·Neuropsychopharmacology ·(unknown), Claire Mokrysz, Tom P. Freeman, Matthew B. Wall, Michael Bloomfield, Rachel Lees, Anna Borissova, Kat Petrilli, James P. Carson, (unknown), (unknown), Christelle Langley, Barbara J. Sahakian, H. Valerie Curran, Will Lawn	15
11	Age differences in the behavioural economics of cannabis use: Do adolescents and adults differ on demand for cannabis and discounting of future reward? 2022 ·Drug and Alcohol Dependence ·Anna Borissova, (unknown), Elizabeth R. Aston, Rachel Lees, Kat Petrilli, (unknown), Michael Bloomfield, (unknown), (unknown), Tom P. Freeman, Claire Mokrysz, Will Lawn, H. Valerie Curran	6
12	Anhedonia, Apathy, Pleasure, and Effort-Based Decision-Making in Adult and Adolescent Cannabis Users and Controls 2022 ·The International Journal of Neuropsychopharmacology ·(unknown), Claire Mokrysz, Tom P. Freeman, Vincent Valton, Matthew B. Wall, Michael Bloomfield, Rachel Lees, Anna Borissova, Kat Petrilli, (unknown), (unknown), Christelle Langley, Barbara J. Sahakian, Valerie H. Curran, Will Lawn	12
13	Cannabinoids for the treatment of cannabis use disorder: New avenues for reaching and helping youth? 2021 ·Neuroscience & Biobehavioral Reviews ·Kristine Rømer Thomsen, Birgitte Thylstrup, (unknown), Rachel Lees, Lone Baandrup, Sarah W. Feldstein Ewing, Tom P. Freeman	9
14	The Effects of Acute Δ9-Tetrahydrocannabinol on Striatal Glutamatergic Function: A Proton Magnetic Resonance Spectroscopy Study 2021 ·Biological Psychiatry Cognitive Neuroscience and Neuroimaging ·Michael Bloomfield, Kat Petrilli, Rachel Lees, Chandni Hindocha, Katherine Beck, (unknown), Ellis Chika Onwordi, Neil Rane, David J. Lythgoe, James Stone, H. Valerie Curran, Oliver Howes, Tom P. Freeman	3
15	Cannabis and cannabidiol use among autistic and non-autistic adults in the UK: a propensity score-matched analysis 2021 ·BMJ Open ·(unknown), Rachel Lees, Mark Brosnan, Tom P. Freeman	4
16	Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review 2021 ·Psychological Medicine ·Rachel Lees, Lindsey A. Hines, Deepak Cyril D’Souza, George Stothart, Marta Di Forti, Eva Hoch, Tom P. Freeman	26
17	Cannabidiol for the treatment of cannabis use disorder: a phase 2a, double-blind, placebo-controlled, randomised, adaptive Bayesian trial 2020 ·The Lancet Psychiatry ·Tom P. Freeman, Chandni Hindocha, Gianluca Baio, (unknown), (unknown), (unknown), Abigail M. Freeman, Rachel Lees, Sam Craft, Paul D. Morrison, Michael Bloomfield, Dominic O’Ryan, (unknown), Celia J. A. Morgan, Ali Mofeez, Valerie H. Curran	139
18	How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review 2019 ·Neuroscience & Biobehavioral Reviews ·Abigail M. Freeman, Kat Petrilli, Rachel Lees, Chandni Hindocha, Claire Mokrysz, Valerie H. Curran, Rob Saunders, Tom P. Freeman	153
19	The neuropsychopharmacology of cannabis: A review of human imaging studies 2018 ·Pharmacology & Therapeutics ·Michael Bloomfield, Chandni Hindocha, Sebastian F Green, Matthew B. Wall, Rachel Lees, Kat Petrilli, Harry Costello, (unknown), Matthijs G. Bossong, Tom P. Freeman	167
20	Nutrition and dietetics for health care. 1996 ·Coventry University Open Collections (Coventry university) ·Helen M. Barker, Rachel Lees	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact